← Back to Clinical Trials
Recruiting NCT06748235

NCT06748235 Comprehensive Hand Repetation Intensive Strength Training on Upper Limb in Children With Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06748235
Status Recruiting
Phase
Sponsor Riphah International University
Condition Cerebral Palsy (CP)
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-09-25
Primary Completion 2024-12-25

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Intensive Strength TrainingRoutine Physical Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-09-25 with a primary completion date of 2024-12-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Hemiplegia is the medical term for paralysis of one side of the body This means their shoulder; arm, hand, leg and foot are all completely paralyzed.. It results in muscular wasting on the affected side, impairs gait, reduces motor abilities, and causes instability and a loss of grasping capacity. The patient\'s quality of life is impacted by hemiplegia because it impairs brain and spinal cord functions Hemiplegic cerebral palsy is the type of cerebral palsy in which there is absolutely no use of one side of the body. This means their shoulder; arm, hand, leg and foot are all completely paralyzed. Hemiplegia in infants and children is a type of Cerebral Palsy that results from damage to the part (hemisphere) of the brain that controls muscle movements. This damage may occur before, during or shortly after birth. The term hemiplegia means that the paralysis is on one vertical half of the body.

Eligibility Criteria

Inclusion Criteria: * Ages 6 to 12 years will be included * Both genders will be included * GMFCS I and II * Children who have normal communication skills and cognitive functions will be included Exclusion Criteria: * Children having damage to the musculoskeletal system including fracture of the upper limb and contracture will be excluded * Children who have undergone the administration of medicine influencing muscular strength and spasticity will be excluded

Contact & Investigator

Central Contact

Imran Amjad Dr, PhD

✉ Imran.amjad@riphah.edu.pk

📞 9233224390125

Principal Investigator

Nisha Feroz, MS

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT06748235 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Cerebral Palsy (CP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06748235 currently recruiting?

Yes, NCT06748235 is actively recruiting participants. Contact the research team at Imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT06748235 trial being conducted?

This trial is being conducted at Lahore, Pakistan, Lahore, Pakistan.

Who is sponsoring the NCT06748235 clinical trial?

NCT06748235 is sponsored by Riphah International University. The principal investigator is Nisha Feroz, MS at Riphah International University. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology